$JAZZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jazz Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Jazz Pharmaceuticals plc. Get notifications about new insider transactions in Jazz Pharmaceuticals plc for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 14 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 163.89 | 1,909 | 312,865 | 382,339 | 384.2 K to 382.3 K (-0.50 %) |
Sep 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 162.71 | 7,894 | 1,284,424 | 384,248 | 392.1 K to 384.2 K (-2.01 %) |
Aug 19 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Option Exercise | M | 46.83 | 667 | 31,236 | 57,606 | |
Aug 19 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Sell | S | 150.00 | 667 | 100,050 | 51,804 | 52.5 K to 51.8 K (-1.27 %) |
Aug 19 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Buy | M | 46.83 | 667 | 31,236 | 52,471 | 51.8 K to 52.5 K (+1.29 %) |
Aug 14 2014 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 133.15 | 1,087 | 144,734 | 14,150 | 15.2 K to 14.2 K (-7.13 %) |
Aug 14 2014 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 133.15 | 1,731 | 230,483 | 5,529 | 7.3 K to 5.5 K (-23.84 %) |
Aug 14 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 133.15 | 1,087 | 144,734 | 3,993 | 5.1 K to 4 K (-21.40 %) |
Aug 14 2014 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 133.15 | 1,087 | 144,734 | 3,993 | 5.1 K to 4 K (-21.40 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 133.86 | 1,956 | 261,830 | 21,713 | 23.7 K to 21.7 K (-8.26 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 59.13 | 2,372 | 140,256 | 17,187 | |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 2,561 | 119,932 | 30,019 | |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 135.42 | 4,933 | 668,027 | 42,538 | 47.5 K to 42.5 K (-10.39 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 59.13 | 2,372 | 140,256 | 47,471 | 45.1 K to 47.5 K (+5.26 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 2,561 | 119,932 | 45,099 | 42.5 K to 45.1 K (+6.02 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Payment of Exercise | F | 133.86 | 4,565 | 611,071 | 42,538 | 47.1 K to 42.5 K (-9.69 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | Head of EUSA Int'l ... | Payment of Exercise | F | 133.86 | 2,729 | 365,304 | 24,824 | 27.6 K to 24.8 K (-9.90 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Sell | S | 133.15 | 1,185 | 157,783 | 51,804 | 53 K to 51.8 K (-2.24 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Payment of Exercise | F | 133.86 | 4,565 | 611,071 | 52,989 | 57.6 K to 53 K (-7.93 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 133.15 | 5,000 | 665,750 | 579,023 | 584 K to 579 K (-0.86 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Payment of Exercise | F | 133.86 | 13,044 | 1,746,070 | 584,023 | 597.1 K to 584 K (-2.18 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Operati ... | Payment of Exercise | F | 133.86 | 4,473 | 598,756 | 60,059 | 64.5 K to 60.1 K (-6.93 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 1,650 | 0 | 15,237 | 13.6 K to 15.2 K (+12.14 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Option Exercise | A | 135.44 | 5,000 | 677,200 | 5,000 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 1,650 | 0 | 7,260 | 5.6 K to 7.3 K (+29.41 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,650 | 0 | 5,006 | 3.4 K to 5 K (+49.17 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Grant | A | 0.00 | 1,650 | 0 | 6,150 | 4.5 K to 6.2 K (+36.67 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Grant | A | 0.00 | 1,650 | 0 | 1,407,205 | 1.4 M to 1.4 M (+0.12 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Grant | A | 0.00 | 1,650 | 0 | 5,650 | 4 K to 5.7 K (+41.25 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Grant | A | 0.00 | 1,650 | 0 | 5,650 | 4 K to 5.7 K (+41.25 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 1,650 | 0 | 5,080 | 3.4 K to 5.1 K (+48.10 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 1,650 | 0 | 5,080 | 3.4 K to 5.1 K (+48.10 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Operati ... | Option Exercise | A | 135.44 | 15,000 | 2,031,600 | 15,000 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Operati ... | Grant | A | 0.00 | 7,500 | 0 | 64,532 | 57 K to 64.5 K (+13.15 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Option Exercise | A | 135.44 | 20,000 | 2,708,800 | 20,000 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jul 10 2014 | JAZZ | Jazz Pharmaceutica ... | Keegan Fintan | EVP, Technical Oper ... | Option Exercise | M | 46.83 | 469 | 21,963 | 8,531 | |
Jul 10 2014 | JAZZ | Jazz Pharmaceutica ... | Keegan Fintan | EVP, Technical Oper ... | Sell | S | 155.00 | 1,991 | 308,605 | 31,750 | 33.7 K to 31.8 K (-5.90 %) |
Jul 10 2014 | JAZZ | Jazz Pharmaceutica ... | Keegan Fintan | EVP, Technical Oper ... | Buy | M | 46.83 | 469 | 21,963 | 33,741 | 33.3 K to 33.7 K (+1.41 %) |
Jul 10 2014 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 155.00 | 5,000 | 775,000 | 597,067 | 602.1 K to 597.1 K (-0.83 %) |
Jul 10 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Option Exercise | M | 46.83 | 1,853 | 86,776 | 58,273 | |
Jul 10 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Sell | S | 155.00 | 1,853 | 287,215 | 57,554 | 59.4 K to 57.6 K (-3.12 %) |
Jul 10 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Buy | M | 46.83 | 1,853 | 86,776 | 59,407 | 57.6 K to 59.4 K (+3.22 %) |
Jul 09 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 27.46 | 2,500 | 68,650 | 10,507 | |
Jul 09 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 165.00 | 2,500 | 412,500 | 23,669 | 26.2 K to 23.7 K (-9.55 %) |
Jul 09 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 27.46 | 2,500 | 68,650 | 26,169 | 23.7 K to 26.2 K (+10.56 %) |
Jun 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 148.64 | 47 | 6,986 | 1,405,555 | 1.4 M to 1.4 M (0.00 %) |
Jun 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 154.54 | 1,044 | 161,340 | 1,405,602 | 1.4 M to 1.4 M (-0.07 %) |
Jun 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 153.06 | 3,800 | 581,628 | 1,406,646 | 1.4 M to 1.4 M (-0.27 %) |
Jun 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 152.10 | 4,500 | 684,450 | 1,410,446 | 1.4 M to 1.4 M (-0.32 %) |
Jun 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 151.36 | 4,000 | 605,440 | 1,414,946 | 1.4 M to 1.4 M (-0.28 %) |
Jun 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 150.19 | 8,896 | 1,336,090 | 1,418,946 | 1.4 M to 1.4 M (-0.62 %) |
Jun 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 149.17 | 7,772 | 1,159,349 | 1,427,842 | 1.4 M to 1.4 M (-0.54 %) |
Jun 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 148.13 | 15,742 | 2,331,862 | 1,435,614 | 1.5 M to 1.4 M (-1.08 %) |
Jun 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 147.08 | 4,199 | 617,589 | 1,451,356 | 1.5 M to 1.5 M (-0.29 %) |
Jun 24 2014 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Operati ... | Sell | S | 155.00 | 2,000 | 310,000 | 57,032 | 59 K to 57 K (-3.39 %) |
Jun 19 2014 | JAZZ | Jazz Pharmaceutica ... | Keegan Fintan | EVP, Technical Oper ... | Sell | S | 150.00 | 3,750 | 562,500 | 33,272 | 37 K to 33.3 K (-10.13 %) |
Jun 11 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 59.13 | 439 | 25,958 | 19,559 | |
Jun 11 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 2,561 | 119,932 | 32,580 | |
Jun 11 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 146.24 | 3,000 | 438,720 | 47,103 | 50.1 K to 47.1 K (-5.99 %) |
Jun 11 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 59.13 | 439 | 25,958 | 50,103 | 49.7 K to 50.1 K (+0.88 %) |
Jun 11 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 2,561 | 119,932 | 49,664 | 47.1 K to 49.7 K (+5.44 %) |
Jun 11 2014 | JAZZ | Jazz Pharmaceutica ... | Keegan Fintan | EVP, Technical Oper ... | Sell | U | 146.24 | 750 | 109,680 | 37,022 | 37.8 K to 37 K (-1.99 %) |
Jun 11 2014 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 142.34 | 5,000 | 711,700 | 602,067 | 607.1 K to 602.1 K (-0.82 %) |
May 29 2014 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 142.49 | 644 | 91,764 | 3,356 | 4 K to 3.4 K (-16.10 %) |
May 29 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Option Exercise | M | 46.83 | 667 | 31,236 | 60,126 | |
May 29 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Sell | S | 140.00 | 667 | 93,380 | 57,135 | 57.8 K to 57.1 K (-1.15 %) |
May 29 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Buy | M | 46.83 | 667 | 31,236 | 57,802 | 57.1 K to 57.8 K (+1.17 %) |
May 20 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 128.01 | 1,000 | 128,010 | 47,103 | 48.1 K to 47.1 K (-2.08 %) |
May 14 2014 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 128.92 | 5,000 | 644,600 | 606,810 | 611.8 K to 606.8 K (-0.82 %) |
May 14 2014 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | SVP & CFO | Option Exercise | A | 130.23 | 288 | 37,506 | 288 | |
May 14 2014 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | SVP & CFO | Option Exercise | A | 130.23 | 12,212 | 1,590,369 | 12,212 | |
May 14 2014 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | SVP & CFO | Grant | A | 0.00 | 6,250 | 0 | 21,880 | 15.6 K to 21.9 K (+39.99 %) |
May 12 2014 | JAZZ | Jazz Pharmaceutica ... | Keegan Fintan | EVP, Technical Oper ... | Sell | S | 136.03 | 750 | 102,023 | 37,772 | 38.5 K to 37.8 K (-1.95 %) |
May 07 2014 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | SVP & CFO | Payment of Exercise | F | 141.98 | 1,127 | 160,011 | 15,630 | 16.8 K to 15.6 K (-6.73 %) |
Apr 21 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Option Exercise | M | 46.83 | 667 | 31,236 | 60,793 | |
Apr 21 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Sell | S | 140.00 | 667 | 93,380 | 57,135 | 57.8 K to 57.1 K (-1.15 %) |
Apr 21 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Buy | M | 46.83 | 667 | 31,236 | 57,802 | 57.1 K to 57.8 K (+1.17 %) |
Apr 21 2014 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 140.00 | 27,500 | 3,850,000 | 13,587 | 41.1 K to 13.6 K (-66.93 %) |
Apr 16 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 59.13 | 1,720 | 101,704 | 19,998 | |
Apr 16 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 1,280 | 59,942 | 35,141 | |
Apr 16 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 128.54 | 3,000 | 385,620 | 48,103 | 51.1 K to 48.1 K (-5.87 %) |
Apr 16 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 59.13 | 1,720 | 101,704 | 51,103 | 49.4 K to 51.1 K (+3.48 %) |
Apr 16 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 1,280 | 59,942 | 49,383 | 48.1 K to 49.4 K (+2.66 %) |
Apr 10 2014 | JAZZ | Jazz Pharmaceutica ... | Keegan Fintan | EVP, Technical Oper ... | Sell | S | 130.00 | 750 | 97,500 | 38,522 | 39.3 K to 38.5 K (-1.91 %) |
Apr 10 2014 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 123.18 | 5,000 | 615,900 | 611,810 | 616.8 K to 611.8 K (-0.81 %) |
Mar 11 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 59.13 | 3,000 | 177,390 | 8,250 | |
Mar 11 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 155.04 | 3,888 | 602,796 | 23,412 | 27.3 K to 23.4 K (-14.24 %) |
Mar 11 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 59.13 | 3,000 | 177,390 | 27,300 | 24.3 K to 27.3 K (+12.35 %) |
Mar 12 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 59.13 | 1,719 | 101,644 | 21,718 | |
Mar 12 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 1,281 | 59,989 | 36,421 | |
Mar 12 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 152.99 | 3,000 | 458,970 | 48,103 | 51.1 K to 48.1 K (-5.87 %) |
Mar 12 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 59.13 | 1,719 | 101,644 | 51,103 | 49.4 K to 51.1 K (+3.48 %) |
Mar 12 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 1,281 | 59,989 | 49,384 | 48.1 K to 49.4 K (+2.66 %) |
Mar 06 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Payment of Exercise | F | 157.60 | 1,174 | 185,022 | 48,103 | 49.3 K to 48.1 K (-2.38 %) |
Mar 06 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 157.60 | 782 | 123,243 | 24,300 | 25.1 K to 24.3 K (-3.12 %) |
Mar 06 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Payment of Exercise | F | 157.60 | 1,547 | 243,807 | 57,135 | 58.7 K to 57.1 K (-2.64 %) |
Mar 06 2014 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | EVP and CFO | Payment of Exercise | F | 157.60 | 1,538 | 242,389 | 133,387 | 134.9 K to 133.4 K (-1.14 %) |
Mar 06 2014 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Payment of Exercise | F | 157.60 | 6,522 | 1,027,867 | 616,810 | 623.3 K to 616.8 K (-1.05 %) |
Mar 06 2014 | JAZZ | Jazz Pharmaceutica ... | Keegan Fintan | EVP, Technical Oper ... | Sell | S | 157.89 | 1,634 | 257,992 | 39,272 | 40.9 K to 39.3 K (-3.99 %) |
Mar 06 2014 | JAZZ | Jazz Pharmaceutica ... | Keegan Fintan | EVP, Technical Oper ... | Sell | S | 161.00 | 3,006 | 483,966 | 40,906 | 43.9 K to 40.9 K (-6.85 %) |
Mar 06 2014 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Commerc ... | Payment of Exercise | F | 157.60 | 1,291 | 203,462 | 58,733 | 60 K to 58.7 K (-2.15 %) |
Mar 05 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 156.25 | 550,000 | 85,937,500 | 1,455,555 | 2 M to 1.5 M (-27.42 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | X | 4.00 | 18,624 | 74,496 | 0 | |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | X | 4.00 | 929,243 | 3,716,972 | 0 | |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 153.80 | 3,895 | 599,043 | 0 | 3.9 K to 0 (-100.00 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 150.45 | 1,166 | 175,429 | 3,895 | 5.1 K to 3.9 K (-23.04 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 149.42 | 3,700 | 552,855 | 5,061 | 8.8 K to 5.1 K (-42.23 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 148.55 | 2,700 | 401,088 | 8,761 | 11.5 K to 8.8 K (-23.56 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 147.87 | 300 | 44,360 | 11,461 | 11.8 K to 11.5 K (-2.55 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 150.50 | 8,731 | 1,314,016 | 7,858 | 16.6 K to 7.9 K (-52.63 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 150.50 | 435,588 | 65,555,994 | 392,142 | 827.7 K to 392.1 K (-52.62 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 159.03 | 559 | 88,897 | 16,589 | 17.1 K to 16.6 K (-3.26 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 159.03 | 28,070 | 4,463,927 | 827,730 | 855.8 K to 827.7 K (-3.28 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 159.91 | 423 | 67,642 | 17,148 | 17.6 K to 17.1 K (-2.41 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 159.91 | 20,977 | 3,354,449 | 855,800 | 876.8 K to 855.8 K (-2.39 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 160.77 | 180 | 28,939 | 17,571 | 17.8 K to 17.6 K (-1.01 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 160.76 | 8,866 | 1,425,330 | 876,777 | 885.6 K to 876.8 K (-1.00 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 161.93 | 787 | 127,442 | 17,751 | 18.5 K to 17.8 K (-4.25 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 161.93 | 39,241 | 6,354,448 | 885,643 | 924.9 K to 885.6 K (-4.24 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 162.94 | 71 | 11,569 | 18,538 | 18.6 K to 18.5 K (-0.38 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 162.94 | 3,645 | 593,906 | 924,884 | 928.5 K to 924.9 K (-0.39 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 164.50 | 1 | 165 | 18,609 | 18.6 K to 18.6 K (-0.01 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 164.50 | 28 | 4,606 | 928,529 | 928.6 K to 928.5 K (0.00 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 165.94 | 14 | 2,323 | 18,610 | 18.6 K to 18.6 K (-0.08 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 165.94 | 686 | 113,835 | 928,557 | 929.2 K to 928.6 K (-0.07 %) |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Buy | X | 4.00 | 18,624 | 74,496 | 18,624 | 0 to 18.6 K |
Mar 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Buy | X | 4.00 | 929,243 | 3,716,972 | 929,243 | 0 to 929.2 K |
Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 166.62 | 647 | 107,803 | 647 | |
Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 166.62 | 6,853 | 1,141,847 | 6,853 | |
Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 46.83 | 11,250 | 526,838 | 15,702 | |
Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Grant | A | 0.00 | 3,750 | 0 | 25,082 | 21.3 K to 25.1 K (+17.58 %) |
Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 166.20 | 3,250 | 540,150 | 21,332 | 24.6 K to 21.3 K (-13.22 %) |
Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 167.00 | 8,000 | 1,336,000 | 24,582 | 32.6 K to 24.6 K (-24.55 %) |
Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 46.83 | 11,250 | 526,838 | 32,582 | 21.3 K to 32.6 K (+52.74 %) |
Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | A | 166.62 | 645 | 107,470 | 645 | |
Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | A | 166.62 | 14,355 | 2,391,830 | 14,355 | |
Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Grant | A | 0.00 | 7,500 | 0 | 49,277 | 41.8 K to 49.3 K (+17.95 %) |
Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 165.46 | 3,000 | 496,380 | 41,777 | 44.8 K to 41.8 K (-6.70 %) |
Mar 03 2014 | JAZZ | Jazz Pharmaceutica ... | Keegan Fintan | EVP, Technical Oper ... | Option Exercise | A | 166.62 | 15,000 | 2,499,300 | 15,000 |